In The Search For New Drugs, Diverging Roads For Microdosing
Subtherapeutic doses in drug development tests have shown important—but unanticipated—advantages
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
January 21, 2013 Cover
Volume 91, Issue 3
Subtherapeutic doses in drug development tests have shown important—but unanticipated—advantages
Cover image:
Credit:
Subtherapeutic doses in drug development tests have shown important—but unanticipated—advantages
California firm values independence as it flaunts its technical competence
Tetsuo Nozoe’s newly published collection of chemists’ signatures and structures showcases 41 years of vital science
Researchers reveal troubling practices and perceptions in laboratories
Unusual deal is a diversification move for growing California firm
Hybrid copper oxide nanorods convert sunlight to photocurrent for driving electrochemical transformations